BRAFTOVI is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Array Biopharma Inc.. The primary component is Encorafenib.
Product ID | 70255-025_026d5ada-5db2-468c-a035-69669558c8b0 |
NDC | 70255-025 |
Product Type | Human Prescription Drug |
Proprietary Name | BRAFTOVI |
Generic Name | Encorafenib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2018-06-27 |
Marketing Category | NDA / NDA |
Application Number | NDA210496 |
Labeler Name | Array BioPharma Inc. |
Substance Name | ENCORAFENIB |
Active Ingredient Strength | 75 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-06-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-06-27 |
Marketing Category | NDA |
Application Number | NDA210496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-06-27 |
Marketing Category | NDA |
Application Number | NDA210496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-09 |
Marketing Category | NDA |
Application Number | NDA210496 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-06-27 |
Ingredient | Strength |
---|---|
ENCORAFENIB | 75 mg/1 |
SPL SET ID: | 235dfc38-0f0b-4037-b501-7a9f4294740c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70255-020 | BRAFTOVI | Encorafenib |
70255-025 | BRAFTOVI | Encorafenib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BRAFTOVI 90021001 not registered Live/Pending |
Array BioPharma Inc. 2020-06-25 |
BRAFTOVI 87077386 5561579 Live/Registered |
Array Biopharma Inc. 2016-06-20 |